208 related articles for article (PubMed ID: 6445103)
1. Effect of splenectomy on specific unresponsiveness to skin allografts induced in ALS-treated, marrow-injected mice.
Wood ML; Gottschalk R; Monaco AP
Transplantation; 1980 Apr; 29(4):320-3. PubMed ID: 6445103
[TBL] [Abstract][Full Text] [Related]
2. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice.
Wood ML; Monaco AP
Transplantation; 1980 Mar; 29(3):196-200. PubMed ID: 6444769
[TBL] [Abstract][Full Text] [Related]
3. Suppressor cells in specific unresponsiveness to skin allografts in thymectomized, ALS-treated, marrow-injected mice.
Wood ML; Gottschalk R; Monaco AP
Transplantation; 1979 Nov; 28(5):387-8. PubMed ID: 160636
[TBL] [Abstract][Full Text] [Related]
4. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
Ohzato H; Monaco AP
Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
[TBL] [Abstract][Full Text] [Related]
5. Effect of granulocyte-macrophage colony-stimulating factor on the induction of unresponsiveness by lymphoid cells.
Monaco AP; Wood ML; Gottschalk R; Seiler FR
Transplantation; 1991 Jan; 51(1):213-8. PubMed ID: 1670970
[TBL] [Abstract][Full Text] [Related]
6. Characterization of spleen cells capable of inducing unresponsiveness in ALS-treated mice.
Wood ML; Monaco AP; Gottschalk R
Transplantation; 1991 Jan; 51(1):208-13. PubMed ID: 1670969
[TBL] [Abstract][Full Text] [Related]
7. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells.
Maki T; Gottschalk R; Wood ML; Monaco AP
J Immunol; 1981 Oct; 127(4):1433-8. PubMed ID: 6168692
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of alloreactive spleen cell-induced second-set skin graft rejection in mice with donor-specific bone marrow cells.
Pourshadi M; De Fazio SR; Gozzo JJ
Transplantation; 1989 May; 47(5):844-7. PubMed ID: 2655223
[TBL] [Abstract][Full Text] [Related]
9. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells.
De Fazio SR; Plowey JM; Hartner WC; Gozzo JJ
Transpl Immunol; 1996 Jun; 4(2):105-12. PubMed ID: 8843586
[TBL] [Abstract][Full Text] [Related]
10. The effect of injection of donor bone marrow on the frequency of donor-reactive CTL in antilymphocyte serum-treated, grafted mice.
Wood ML; Orosz CG; Gottschalk R; Monaco AP
Transplantation; 1992 Oct; 54(4):665-71. PubMed ID: 1412758
[TBL] [Abstract][Full Text] [Related]
11. Analysis of donor reactive cells in ALS-treated mice bearing skin allografts after the intrathymic injection of donor specific spleen cells.
Ohzato H; Wood ML; Gottschalk R; Monaco AP
Transpl Immunol; 1995 Mar; 3(1):33-8. PubMed ID: 7551976
[TBL] [Abstract][Full Text] [Related]
12. Induction of antigen-specific unresponsiveness to pancreatic islet allografts by antilymphocyte serum.
Gotoh M; Porter J; Monaco AP; Maki T
Transplantation; 1988 Feb; 45(2):429-33. PubMed ID: 2449750
[TBL] [Abstract][Full Text] [Related]
13. Effect of posttransplantation administration of peripheral blood lymphocytes in skin-grafted mice treated with antilymphocyte serum or antilymphocyte serum plus bone marrow.
De Fazio SR; Hartner WC; Monaco AP; Gozzo JJ
Transplantation; 1987 Jul; 44(1):70-5. PubMed ID: 3299924
[TBL] [Abstract][Full Text] [Related]
14. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
Transplantation; 1997 Feb; 63(3):359-64. PubMed ID: 9039923
[TBL] [Abstract][Full Text] [Related]
15. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
Fukuzaki T; Hancock WW; Monaco AP; Maki T
Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
[TBL] [Abstract][Full Text] [Related]
16. Suppressor cells in mice bearing intact skin allografts after blood transfusions.
Maki T; Okazaki H; Wood ML; Monaco AP
Transplantation; 1981 Dec; 32(6):463-6. PubMed ID: 6461952
[TBL] [Abstract][Full Text] [Related]
17. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
Dono K; Maki T; Wood ML; Monaco AP
Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
[TBL] [Abstract][Full Text] [Related]
18. Allograft and xenograft unresponsiveness induced by transplantation of neonatal skin.
Jamshidi F; De Fazio SR; Gozzo JJ
Transplantation; 1993 Jul; 56(1):135-8. PubMed ID: 8333035
[TBL] [Abstract][Full Text] [Related]
19. Induction of unresponsiveness to skin allografts in adult mice disparate at defined regions of the H-2 complex. I. Effect of donor-specific bone marrow in ALS-treated mice.
Wood ML; Monaco AP
Transplantation; 1984 Jan; 37(1):35-9. PubMed ID: 6364486
[TBL] [Abstract][Full Text] [Related]
20. The effect of cyclophosphamide on the splecific unresponsiveness to skin allografts induced in ALS-treated mice infused with donor bone marrow.
Wood ML; Monaco AP
J Immunol; 1977 Apr; 118(4):1456-9. PubMed ID: 321691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
